GlassScriptPhysician profile
Peter Anthony Jakacki
NPI 1669463089
$18,778.29
in general payments reported to CMS, 2019-2025
10 companies · $33.89 in 2025
The $33.89 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,181 · 2021: $226 · 2022: $4,182 · 2023: $42.19 · 2024: $122 · 2025: $33.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17,972.86 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $240.08 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $122.30 | 2024 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $121.39 | 2022 | |
| Insulet Corporation | $99.62 | 2019 | |
| Dexcom, INC. | $90.54 | 2020-2022 | |
| Glaxosmithkline, LLC. | $41.24 | 2019 | |
| Sunovion Pharmaceuticals INC. | $35.52 | 2019 | |
| Beta Bionics, INC. | $33.89 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Lilly USA, LLC | $20.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Jakacki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.